Financials genXone S.A.

Equities

GX1

PLGENXN00013

Pharmaceuticals

End-of-day quote Warsaw S.E. 23:00:00 22/05/2024 BST 5-day change 1st Jan Change
5.9 PLN -0.34% Intraday chart for genXone S.A. -7.23% +9.67%

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 69.13 69.2 33.67
Enterprise Value (EV) 1 63.05 54.96 22.51
P/E ratio 9.66 x 7.89 x 70.2 x
Yield 3.1% 4.76% -
Capitalization / Revenue 3.38 x 2.98 x 3.18 x
EV / Revenue 3.08 x 2.37 x 2.13 x
EV / EBITDA 7 x 4.69 x 12.6 x
EV / FCF 55.2 x 5.8 x 38.7 x
FCF Yield 1.81% 17.2% 2.58%
Price to Book 4.65 x 3.22 x 1.8 x
Nbr of stocks (in thousands) 3,295 3,295 3,295
Reference price 2 20.98 21.00 10.22
Announcement Date 28/05/21 28/04/22 21/04/23
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales 1 0.2046 20.47 23.2 10.59
EBITDA 1 -0.9834 9.007 11.73 1.783
EBIT 1 -1.017 8.839 10.56 0.2381
Operating Margin -497.04% 43.17% 45.52% 2.25%
Earnings before Tax (EBT) 1 -1.073 8.65 10.54 0.6301
Net income 1 -1.077 7.157 8.773 0.48
Net margin -526.61% 34.96% 37.82% 4.53%
EPS - 2.172 2.662 0.1457
Free Cash Flow 1 -1.382 1.142 9.469 0.5813
FCF margin -675.6% 5.58% 40.82% 5.49%
FCF Conversion (EBITDA) - 12.68% 80.75% 32.6%
FCF Conversion (Net income) - 15.96% 107.94% 121.1%
Dividend per Share - 0.6500 1.000 -
Announcement Date 28/05/21 28/05/21 28/04/22 21/04/23
1PLN in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 0.28 - - -
Net Cash position 1 - 6.08 14.2 11.2
Leverage (Debt/EBITDA) -0.2885 x - - -
Free Cash Flow 1 -1.38 1.14 9.47 0.58
ROE (net income / shareholders' equity) -39.9% 76.8% 48.2% 2.39%
ROA (Net income/ Total Assets) -11% 44.5% 30.9% 0.67%
Assets 1 9.767 16.08 28.42 72.16
Book Value Per Share - 4.510 6.530 5.670
Cash Flow per Share - 1.850 4.320 3.390
Capex 1 0.35 1.63 0.9 0.52
Capex / Sales 172.88% 7.95% 3.89% 4.94%
Announcement Date 28/05/21 28/05/21 28/04/22 21/04/23
1PLN in Million
Estimates
  1. Stock Market
  2. Equities
  3. GX1 Stock
  4. Financials genXone S.A.